在美国医疗保健系统中克服华法林患者自我管理的障碍:实施试验研究协议
Heeseung Hong1,2, Aaron S Wilson1, Aubrey E Jones1,2
1University of Utah College of Pharmacy, Salt Lake City, Utah.
medRxiv : the preprint server for health sciences
|September 2, 2025
概括
虽然华法林治疗的患者自我管理 (PSM) 是有效的,但在美国尚未得到充分利用. 这项研究实施了PSM策略,以改善美国医疗保健系统的华法林管理和患者结果.
科学领域:
- 药理学
- 医疗服务研究
- 实施科学
背景情况:
- 华法林是一种狭窄的治疗指数药物,需要定期监测国际标准化比率 (INR).
- 目前的临床INR监测往往导致华法林管理不足.
- 华法林患者自我管理 (PSM) 显示出优异的疗效,但在美国很少使用.
研究的目的:
- 在美国医疗保健系统内实施华法林患者自我管理 (PSM).
- 应对已发现的障碍,并利用促成采用PSM的因素.
- 评估公共安全管理战略的实施和有效性.
主要方法:
- 将采用一种 III 型混合实施效率研究设计.
- 四个地区的150名成年患者将参与PSM的实施.
- 实施研究的综合框架和质量实施框架将指导战略,并支持快速循环研究方法.
主要成果:
- 该研究将评估PSM实施战略的成果.
- 将使用RE-AIM框架 (覆盖范围,有效性,采用,实施,维护) 评估PSM的临床结果.
- 伦理委员会将获得所有参与网站的批准.
结论:
- 这项研究旨在证明PSM在美国抗凝血服务中的可行性.
- 实施成功可以改善华法林管理和患者护理.
- 研究结果将通过出版物,会议和公开工具包进行传播.
相关概念视频
Venous Thrombosis III: Interprofessional Care
22
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
22
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.3K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.3K
Venous Thrombosis IV: Nursing Management
22
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
22
Anticoagulant Drugs: Low-Molecular-Weight Heparins
889
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
889
Peripheral Artery Disease IV: Nursing Management
43
The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses,...
43
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
644
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
644


